Chinook Therapeutics Inc KDNY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
13.91UNCH (UNCH)
Volume
373
Close
13.91quote price arrow up+0.31 (+2.28%)
Volume
143,654
52 week range
10.50 - 21.68

...

Loading . . .
  • Open13.56
  • Day High14.27
  • Day Low13.56
  • Prev Close13.60
  • 52 Week High21.68
  • 52 Week High Date12/17/20
  • 52 Week Low10.50
  • 52 Week Low Date06/26/20

Key Stats

  • Market Cap589.51M
  • Shares Out42.38M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta0.04
  • YTD % Change-12.3

KEY STATS

  • Open13.56
  • Day High14.27
  • Day Low13.56
  • Prev Close13.60
  • 52 Week High21.68
  • 52 Week High Date12/17/20
  • 52 Week Low10.50
  • 52 Week Low Date06/26/20
  • Market Cap589.51M
  • Shares Out42.38M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta0.04
  • YTD % Change-12.3

RATIOS/PROFITABILITY

  • EPS (TTM)-6.20
  • P/E (TTM)-2.24
  • Fwd P/E (NTM)-5.96
  • EBITDA (MRQ)-53.195M
  • ROE (MRQ)-40.79%
  • Revenue (MRQ)830,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-9,869.65%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Chinook Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Chinook Therapeutics, Inc., formerly Aduro Biotech, Inc., is a clinical-stage biotechnology company. The Company develops precision medicines for kidney diseases. The Company’s products focus on severe chronic kidney disorders. The Company assembled a portfolio of precision medicines product candidates designed to address severe chronic kidney diseases. Its development programs consist of atrasentan, BION-1301 and CHK-336. Atrasentan, a potent and selective endothelin...
Eric Dobmeier J.D.
President
Eric Bjerkholt
Chief Financial Officer
Address
1600 FAIRVIEW AVE E.
Seattle, WA
98102
United States

Top Peers

SYMBOLLASTCHG%CHG
XENE
Xenon Pharmaceuticals Inc
18.12+0.59+3.37%
IDYA
IDEAYA Biosciences Inc
18.11+0.35+1.97%
HARP
Harpoon Therapeutics Inc
19.86-0.38-1.88%
MGTX
MeiraGTx Holdings PLC
13.60+0.52+3.98%
KDMN
Kadmon Holdings Inc
3.62-0.06-1.63%